ART in HIV and factors affecting adherence to ART among HIV-positive individuals: a review

Hemant Kharkwal; Jhuma Samanta; Srishti Kharkwal

doi:10.18203/2394-6040.ijcmph20264133

Authors

Hemant Kharkwal Department of Public Health, School of Pharmaceutical Science, Jigyasa University, Dehradun, Uttarakhand, India
Jhuma Samanta Department of Public Health, School of Pharmaceutical Science, Jigyasa University, Dehradun, Uttarakhand, India
Srishti Kharkwal Department of Dravyaguna, Patanjali Bhartiya Ayurvigyan Evam Anusandhan Sansthan, Haridwar, Uttarakhand, India

DOI:

https://doi.org/10.18203/2394-6040.ijcmph20264133

Keywords:

Adherence, ART, Human immunodeficiency virus, Factors, AIDS

Abstract

Anti-Retroviral Therapy (ART) has greatly enhanced the quality of life for individuals living with Human Immunodeficiency Virus (HIV) globally. In regions where ART is widely accessible, there has been a noticeable decline in HIV-related illness and death, making Acquired Immune Deficiency Syndrome (AIDS) a manageable chronic condition. For ART to be most effective, patients must maintain a high level of adherence. Consistent adherence is essential to achieve the full benefits of treatment and to prevent the development of drug resistance. Despite this, numerous barriers to adherence exist in both developed and developing countries. This review aims to examine the impact of HIV, evaluate adherence rates, and identify factors that influence adherence to ART among people living with HIV. It highlights the importance of providing intensive adherence counseling before starting therapy. Healthcare providers should also identify potential obstacles to adherence early and implement appropriate strategies to address them.

References

HIV/AIDS in places of detention: a toolkit for policy makers, managers and staff. UNODC, WHO. Accessed October 26, 2025.

Paterson DL, Swindells S, Mohr J, Brester M, Vergis EN, Squier C, et al. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med. 2000;133:21–30.

National AIDS Control Organisation. National guidelines for HIV care and treatment. Ministry of Health and Family Welfare, Government of India; 2021.

World Health Organization. HIV statistics, globally and by WHO region; 2024. Accessed November 17, 2025.

National AIDS Control Organisation. National AIDS and STD Control Programme Phase V, 2021–2026. Ministry of Health and Family Welfare, Government of India; 2021.

National AIDS Control Organisation. India HIV estimates: technical report. Ministry of Health and Family Welfare, Government of India; 2023.

Rivera-Picón C, Benavente-Cuesta MH, Quevedo-Aguado MP, Sánchez-González JL, Rodríguez-Muñoz PM. Factors associated with adherence to treatment in patients with HIV and diabetes mellitus. J Pers Med. 2023;13(2):269.

Gupta PK, Saxena A. HIV/AIDS: current updates on the disease, treatment, and prevention. Proc Natl Acad Sci India Sect B Biol Sci. 2021;91(3):495–510.

Centers for Disease Control and Prevention. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents; 2022.

European AIDS Clinical Society. European guidelines for treatment of HIV-infected adults in Europe; 2022.

International AIDS Society–USA. Antiretroviral treatment guidelines; 2022.

World Health Organization. Antiretroviral treatment working group treatment white paper; 2010.

Lakshmi MG. Impact of psychoeducation on stigma and quality of life in people living with HIV/AIDS [dissertation]. University of Mysore, Department of Psychology; 2014.

National AIDS Control Organisation. NACO guidelines; 2021. Accessed October 30, 2025.

Gangte L, Popli UK. Assessment of drug adherence to antiretroviral therapy among patients in Churachandpur district, Manipur. Department of Social Work, Jamia Millia Islamia University; 2016.

Holstad MM, DiIorio C, Kelley ME, Resnicow K, Sharma S. Group motivational interviewing to promote adherence to antiretroviral medications and risk-reduction behaviors in HIV-infected women. AIDS Behav. 2010.

Kilbourne AM, Reynolds CF, Good CB, Sereika SM, Justice AC, Fine MJ. How does depression influence diabetes medication adherence in older patients? Am J Geriatr Psychiatry. 2005;13(3):202–10.

Tucker JS, Orlando M, Burnam MA, Sherbourne CD, Kung FY, Gifford AL. Psychosocial mediators of antiretroviral nonadherence in HIV-positive adults with substance use and mental health problems. Health Psychol. 2004;23(4):363–70.

Coetzee B, Kagee A, Vermeulen N. Structural barriers to adherence to antiretroviral therapy in a resource-constrained setting: the perspectives of health care providers. AIDS Care. 2011;23(2):146–51.

Mills EJ, Nachega JB, Bangsberg DR, Singh S, Rachlis B, Wu P, et al. Adherence to HAART: a systematic review of developed and developing nation patient-reported barriers and facilitators. PLoS Med. 2006;3(11):e438.

Kagee A, Remien RH, Berkman A, Hoffman S, Campos L, Swartz L. Structural barriers to ART adherence in Southern Africa: challenges and potential ways forward. Glob Public Health. 2011;6(1):83–97.

Kagee A, Le Roux M, Dick J. Treatment adherence among primary care patients in a historically disadvantaged community in South Africa: a qualitative study. J Health Psychol. 2007;12(3):444–60.

Holstad MKM, Pace JC, De AK, Ura DR. Factors associated with adherence to antiretroviral therapy. J Assoc Nurses AIDS Care. 2006;17(2):4–15.

Hardon AP, Akurut D, Comoro C, Ekezie C, Irunde HF, Gerrits T, et al. Hunger, waiting time and transport costs: time to confront challenges to ART adherence in Africa. AIDS Care. 2007;19(5):658–65.

Largu MA, Oprea L, Manciuc C. Adherence to antiretroviral therapy in HIV/AIDS-infected individuals: reasons for non-adherence in the HIV-positive population of northeastern Romania. Soc Res Rep. 2015;27.

Nattrass N. AIDS, science and governance: the battle over antiretroviral therapy in post-apartheid South Africa. Southern African HIV Clinicians Journal. 2006. Available from: http://www.aidstruth.org/Rolling-out-HAART-in-SouthAfrica.pdf, Accessed on 10-Jun-26

Levine AJ, Hinkin CH, Castellon SA, Mason KI, Lam MN, Perkins A, et al. Variations in patterns of highly active antiretroviral therapy (HAART) adherence. AIDS Behav. 2005;9(3):355–62.

Jones D, Cook R, Rodriguez A, Waldrop-Valverde D. Personal HIV knowledge, appointment adherence and HIV outcomes. AIDS Behav. 2012;2(2):67–80.

Atanga MBS, Akenji JF, Atashili J, Nde FP. Can support group membership enhance knowledge of ART and adherence? Views and quotes from people living with HIV/AIDS in the Fako Division, SWR, Cameroon; 2015.

De Fátima Bonolo P, Ceccato MDGB, Rocha GM, de Assis Acúrcio F, Campos LN, Guimarães MDC. Gender differences in nonadherence among Brazilian patients initiating antiretroviral therapy. Clinics (Sao Paulo). 2013;68(5):612–20.

Kermode M, Devine A, Chandra P, Dzuvichu B, Gilbert T, Herrman H. Some peace of mind: assessing a pilot intervention to promote mental health among widows of injecting drug users in north-east India. BMC Public Health. 2008;8:1.

DiMatteo MR. Variations in patients’ adherence to medical recommendations: a quantitative review of 50 years of research. Med Care. 2004;42(3):200–9.

Coetzee B, Kagee A, Vermeulen N. Structural barriers to adherence to antiretroviral therapy in a resource-constrained setting: the perspectives of health care providers. AIDS Care. 2011;23(2):146–51.

Mathes T, Pieper D, Antoine SL, Eikermann M. Adherence-enhancing interventions for highly active antiretroviral therapy in HIV-infected patients: a systematic review. HIV Med. 2013;14(10):583–95.

Catz S, Heckman T, Kochman A. Adherence to HAART therapy among older adults living with HIV disease. In: Fourth International Conference on the Biophysical Aspects of HIV Infection; Ottawa, Canada; 1999. Poster 18.

Atanga MBS, Akenji JF, Atashili J, Nde FP. Can support group membership enhance knowledge of ART and adherence? Views and quotes from people living with HIV/AIDS in the Fako Division, SWR, Cameroon; 2015.

Hegazi A, et al. Literacy, education and adherence to antiretroviral therapy in The Gambia. AIDS Care. 2010;22(11):1340–5.

Wolf MS. Literacy, self-efficacy, and HIV medication adherence. Patient Educ Couns. 2007;65(2):253–60.

Karim SSA, Churchyard GJ, Karim QA, Lawn SD. HIV infection and tuberculosis in South Africa: an urgent need to escalate the public health response. Lancet. 2009;374(9693):921–33.

Shumaker SA, Brownell A. Introduction: social support interventions. J Soc Issues. 1984;40(1):1–4.

Cox LE. Social support, medication compliance and HIV/AIDS. Soc Work Health Care. 2002;35(1–2):425–60.

Simoni JM, Kurth AE, Pearson CR, Pantalone DW, Merrill JO, Frick PA. Self-report measures of antiretroviral therapy adherence: a review with recommendations for HIV research and clinical management. AIDS Behav. 2006;10(3):227–45.

Sahay S, Reddy KS, Dhayarkar S. Optimizing adherence to antiretroviral therapy. Indian J Med Res. 2011:835–49.

Eramova I, Matic S, Munz M. HIV/AIDS treatment and care: clinical protocols for the WHO European Region. Copenhagen: WHO Regional Office for Europe; 2007.

Kaboré L, Muntner P, Chamot E, Zinski A, Burkholder G, Mugavero MJ. Self-report measures in the assessment of antiretroviral medication adherence: comparison with medication possession ratio and HIV viral load. J Int Assoc Provid AIDS Care. 2014:156–62.

Muñoz-Moreno JA, Fumaz CR, Ferrer JM, Tuldra A, Rovira T, Viladrich C, et al. Assessing self-reported adherence to HIV therapy by questionnaire: the SERAD (Self-Reported Adherence) study. AIDS Res Hum Retroviruses. 2007:1166–75.

Chalker JC, Andualem T, Gitau LN, Ntaganira J, Obua C, Tadeg H, et al. Measuring adherence to antiretroviral treatment in resource-poor settings: the feasibility of collecting routine data for key indicators. BMC Health Serv Res. 2010.

Lu M, Safren AS, Skolnik PR, Rogers WH, Coady W, Hardy H. Optimal recall period and response task for self-reported HIV medication adherence. AIDS Behav. 2008:86–94.

McKinney O, Pearce D, Banta J, Mataya R, Muula A, Crounse J, et al. Evaluation of pill-count adherence with self-reported adherence in assessing antiretroviral therapy behavior of women living with HIV at a faith-based clinic in Malawi. HIV Curr Res. 2017:1–6.

Platt MO, Evans D, Keegan PM, McNamara L, Parker IK, Roberts LM, et al. Low-cost method to monitor patient adherence to HIV antiretroviral therapy using multiplex cathepsin zymography. Mol Biotechnol. 2017:56–64.

Population Council. Adherence to antiretroviral therapy in adults: a guide for trainers. Nairobi, Kenya: Population Council; 2004.